GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RUA Life Sciences PLC (LSE:RUA) » Definitions » Total Assets

RUA Life Sciences (LSE:RUA) Total Assets : £8.17 Mil (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is RUA Life Sciences Total Assets?

RUA Life Sciences's Total Assets for the quarter that ended in Mar. 2024 was £8.17 Mil.

Warning Sign:

If a company builds assets at 42.5% a year, faster than its revenue growth rate of 18.9% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, RUA Life Sciences's average Total Assets Growth Rate was 1.40% per year. During the past 3 years, the average Total Assets Growth Rate was 3.20% per year. During the past 5 years, the average Total Assets Growth Rate was 42.50% per year. During the past 10 years, the average Total Assets Growth Rate was 16.40% per year.

During the past 13 years, RUA Life Sciences's highest 3-Year average Total Assets Growth Rate was 129.50%. The lowest was -60.50%. And the median was 2.90%.

Total Assets is connected with ROA %. RUA Life Sciences's annualized ROA % for the quarter that ended in Mar. 2024 was -13.31%. Total Assets is also linked to Revenue through Asset Turnover. RUA Life Sciences's Asset Turnover for the quarter that ended in Mar. 2024 was 0.22.


RUA Life Sciences Total Assets Historical Data

The historical data trend for RUA Life Sciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RUA Life Sciences Total Assets Chart

RUA Life Sciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.49 10.16 7.63 5.66 8.17

RUA Life Sciences Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.63 6.60 5.66 4.75 8.17

RUA Life Sciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

RUA Life Sciences's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=7.182+0.987
=8.17

RUA Life Sciences's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=7.182+0.987
=8.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RUA Life Sciences  (LSE:RUA) Total Assets Explanation

Total Assets is connected with ROA %.

RUA Life Sciences's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=-0.86/( (4.754+8.169)/ 2 )
=-0.86/6.4615
=-13.31 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

RUA Life Sciences's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1.397/( (4.754+8.169)/ 2 )
=1.397/6.4615
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

RUA Life Sciences Total Assets Related Terms

Thank you for viewing the detailed overview of RUA Life Sciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


RUA Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
2 Drummond Crescent, Ayrshire, Scotland, Irvine, GBR, KA11 5AN
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives the majority of its revenue from the USA and has a presence in Switzerland, Italy, the UK, and Israel.

RUA Life Sciences Headlines

No Headlines